EXTH-43. GENERATION OF A B-CELL-BASED VACCINE FOR THE TREATMENT OF GLIOBLASTOMA

Immunotherapy has revolutionized the treatment of many tumors. However, most glioblastoma (GBM) patients have not, so far, benefited from such successes. With the goal of exploring ways to boost anti-GBM immunity, we developed a B-cell-based vaccine (B(Vax)) that consists of 4-1BBL(+) B cells activa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Lee Chang, Catalina, Miska, Jason, Hou, David, Rashidi, Aida, Zhang, Peng, Burga, Rachel, Torres, Ignacio Jusue, Xiao, Ting, Arrieta, Victor, Zhang, Daniel, Lopez-Rosas, Aurora, Han, Yu, Sonabend, Adam, Horbinski, Craig, Stupp, Roger, Balyasnikova, Irina, Lesniak, Maciej
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Preclinical Experimental Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651425/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.397
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares